NYSE · Consumer Staples
Guardian Pharmacy Services, Inc. (GRDN)
As-reported financials and recent SEC filings for Guardian Pharmacy Services, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.45B
Net income
$49.2M
Net margin
3.4%
Diluted EPS
—
ROE
22.6%
P/E (TTM)
50.4×
Market cap
$2.68B
Debt / equity
0.0×
Income statement (as reported)
| Line | FY2025 | FY2025 |
|---|---|---|
| Revenue | $1.45B | $1.23B |
| Gross profit | $292.7M | $244.4M |
| Operating income | $72.7M | $-62.9M |
| Net income | $49.2M | $-110.0M |
| Diluted EPS | — | — |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-22
View on EDGAR →8-K2026-05-28
View on EDGAR →42026-05-07
View on EDGAR →42026-05-07
View on EDGAR →42026-05-07
View on EDGAR →8-K2026-05-07
View on EDGAR →S-82026-05-06
View on EDGAR →S-3ASR2026-05-06
View on EDGAR →Go deeper on GRDN
Search Guardian Pharmacy Services, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.